Until now, the rules -- governing aspects of the industry like how closely utilities monitor their transmission lines and how much information they share with other regions -- have been drafted by an industry group, the North American Electric Reliability Council.
The proposals were drafted by an industry study group whose work began in late 2007 but became far more urgent in September, when a run on a giant money fund forced the Treasury Department to set up an ad hoc insurance program to stem a panic in the nearly $4 trillion money fund market.
A measure drafted by an industry group specifically to ensure that its members are first in line for any marijuana business permits is obviously problematic.
ACCURACY In 2003 Mr. McCain joined with Senator Joseph I. Lieberman, then a Connecticut Democrat, to draft a bill requiring industries to cut emissions of carbon dioxide.
The Federal Aviation Administration, scrambling to keep up, has set up an industry advisory panel to draft new rules by the end of the month.
The FDA published a draft Guidance for Industry: Adaptive Design Clinical Trials for Drugs and Biologics in February 2010 [ 4].
In July 2011, the FDA issued a draft guidance for industry for "in vitro companion diagnostic devices", which are predictive biomarkers essential for safe and effective use of a corresponding therapeutic product (Food and Drug Administration 2011).
The FDA also published a draft Guidance for Industry: Enrichment Strategies for Clinical trials to support approval of human drugs and biological products in December 2012 which includes adaptive elements [ 5].
In 2009, the FDA provided a draft guidance to industry for the development, analysis, and presentation of microbiologic data for new systemic antibiotics, and described how provisional breakpoints are established using PK PD data before initiation of phase III clinical trials.
The FDA has recently issued a draft, "Guidance for Industry: Pharmacogenomic Data Submissions" (FDA 2003), and has held workshops to discuss issues related to pharmacogenomics data submissions (Salerno and Lesko 2004a, 2004b; Leighton et al. 2004; Ruaño et al. 2004; Trepicchio et al. 2004).
